E2 ModerateModerate confidencePEM unclearCross-SectionalPeer-reviewedMachine draft
No association of xenotropic murine leukemia virus-related virus with prostate cancer or chronic fatigue syndrome in Japan.
Furuta, Rika A, Miyazawa, Takayuki, Sugiyama, Takeki et al. · Retrovirology · 2011 · DOI
Quick Summary
Researchers tested blood samples from 500 healthy people, 67 prostate cancer patients, and 100 ME/CFS patients in Japan to see if a virus called XMRV was linked to these conditions. They found some antibodies to XMRV in a small number of people (1.6-3.0%), but no clear evidence of active infection in any group, suggesting XMRV is not a cause of ME/CFS in Japan.
Why It Matters
During the 2000s-2010s, XMRV was proposed as a potential infectious cause of ME/CFS, generating significant hope and controversy. This negative finding in a carefully designed Japanese population study helped clarify that XMRV is not consistently associated with ME/CFS, contributing to the scientific consensus that earlier XMRV-CFS reports were likely false positives.
Observed Findings
- Anti-XMRV Gag antibodies were detected in 1.6-3.0% of healthy donors, prostate cancer patients, and ME/CFS patients with no significant difference by group.
- Antibody-positive individuals showed specificity to XMRV Gag capsid protein but lacked strong antibody responses to multiple XMRV proteins.
- XMRV DNA was not detected in peripheral blood mononuclear cells from any of the 100 ME/CFS patients tested.
- Occasional XMRV gene fragments were detected in plasma or blood cells from some prostate cancer patients, but no infectious or full-length virus was isolated.
Inferred Conclusions
- There is no solid evidence of XMRV infection in Japanese healthy donors, prostate cancer patients, or ME/CFS patients.
- The presence of anti-XMRV antibodies in small fractions of all groups regardless of disease status suggests these antibodies are not disease-specific markers.
- XMRV is not associated with the onset of ME/CFS in the Japanese population studied.
- Antibodies detected may represent cross-reactivity or exposure to related viruses rather than genuine XMRV infection.
Remaining Questions
- Do the detected anti-XMRV antibodies represent true infection, cross-reactivity with other viruses, or laboratory artifacts?
What This Study Does Not Prove
This study does not prove XMRV causes ME/CFS globally—the results apply specifically to Japan and may not generalize to other populations. The presence of some anti-XMRV antibodies in healthy people suggests potential cross-reactivity or past exposure to related viruses, so the meaning of these antibodies remains unclear. A negative finding does not rule out XMRV's role in other geographic regions or in subgroups not captured by this sample.
Tags
Symptom:Fatigue
Biomarker:Blood Biomarker
Method Flag:Weak Case DefinitionNo ControlsSmall Sample
Metadata
- DOI
- 10.1186/1742-4690-8-20
- PMID
- 21414229
- Review status
- Machine draft
- Evidence level
- Single-study or moderate support from human research
- Last updated
- 8 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →